177 related articles for article (PubMed ID: 37220064)
1. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer.
Bifarin OO; Sah S; Gaul DA; Moore SG; Chen R; Palaniappan M; Kim J; Matzuk MM; Fernández FM
J Proteome Res; 2023 Jun; 22(6):2092-2108. PubMed ID: 37220064
[TBL] [Abstract][Full Text] [Related]
2. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer.
Bifarin OO; Sah S; Gaul DA; Moore SG; Chen R; Palaniappan M; Kim J; Matzuk MM; Fernández FM
bioRxiv; 2023 Jan; ():. PubMed ID: 36711577
[TBL] [Abstract][Full Text] [Related]
3. Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model.
Huang D; Gaul DA; Nan H; Kim J; Fernández FM
J Proteome Res; 2019 Aug; 18(8):3184-3194. PubMed ID: 31290664
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model.
Jones CM; Monge ME; Kim J; Matzuk MM; Fernández FM
J Proteome Res; 2015 Feb; 14(2):917-27. PubMed ID: 25567202
[TBL] [Abstract][Full Text] [Related]
5. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.
Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS
J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240
[TBL] [Abstract][Full Text] [Related]
6. Space- and Time-Resolved Metabolomics of a High-Grade Serous Ovarian Cancer Mouse Model.
Sah S; Ma X; Botros A; Gaul DA; Yun SR; Park EY; Kim O; Moore SG; Kim J; Fernández FM
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565391
[TBL] [Abstract][Full Text] [Related]
7. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
8. Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors.
Lanfredi GP; Thomé CH; Ferreira GA; Silvestrini VC; Masson AP; Vargas AP; Grassi ML; Poersch A; Candido Dos Reis FJ; Faça VM
Biochim Biophys Acta Proteins Proteom; 2021 Jun; 1869(6):140623. PubMed ID: 33607274
[TBL] [Abstract][Full Text] [Related]
9. Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer.
Medrano M; Communal L; Brown KR; Iwanicki M; Normand J; Paterson J; Sircoulomb F; Krzyzanowski P; Novak M; Doodnauth SA; Saiz FS; Cullis J; Al-Awar R; Neel BG; McPherson J; Drapkin R; Ailles L; Mes-Massons AM; Rottapel R
Cell Rep; 2017 Mar; 18(10):2343-2358. PubMed ID: 28273451
[TBL] [Abstract][Full Text] [Related]
10. Ultrahigh Resolution Lipid Mass Spectrometry Imaging of High-Grade Serous Ovarian Cancer Mouse Models.
Ma X; Botros A; Yun SR; Park EY; Kim O; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM
bioRxiv; 2023 Nov; ():. PubMed ID: 37961688
[TBL] [Abstract][Full Text] [Related]
11. Lipid Alterations in Early-Stage High-Grade Serous Ovarian Cancer.
Iurova MV; Chagovets VV; Pavlovich SV; Starodubtseva NL; Khabas GN; Chingin KS; Tokareva AO; Sukhikh GT; Frankevich VE
Front Mol Biosci; 2022; 9():770983. PubMed ID: 35495636
[TBL] [Abstract][Full Text] [Related]
12. Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models.
Ma X; Botros A; Yun SR; Park EY; Kim O; Park S; Pham TH; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM
Front Chem; 2023; 11():1332816. PubMed ID: 38260043
[TBL] [Abstract][Full Text] [Related]
13. Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes.
Govindarajan M; Ignatchenko V; Ailles L; Kislinger T
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671461
[TBL] [Abstract][Full Text] [Related]
14. Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis.
Kobayashi H; Ogawa K; Kawahara N; Iwai K; Niiro E; Morioka S; Yamada Y
Free Radic Res; 2017 Oct; 51(9-10):755-764. PubMed ID: 28931330
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging.
Sans M; Gharpure K; Tibshirani R; Zhang J; Liang L; Liu J; Young JH; Dood RL; Sood AK; Eberlin LS
Cancer Res; 2017 Jun; 77(11):2903-2913. PubMed ID: 28416487
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer.
Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Arko D; Takač I
Clin Chim Acta; 2018 Jun; 481():108-114. PubMed ID: 29481776
[TBL] [Abstract][Full Text] [Related]
17. Targeted Genomic Sequencing Reveals Novel
Jung YY; Woo HY; Kim HS
Anticancer Res; 2019 Jun; 39(6):2883-2889. PubMed ID: 31177126
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics Reveals Altered Lipid Metabolism in a Mouse Model of Endometriosis.
Dutta M; Anitha M; Smith PB; Chiaro CR; Maan M; Chaudhury K; Patterson AD
J Proteome Res; 2016 Aug; 15(8):2626-33. PubMed ID: 27246581
[TBL] [Abstract][Full Text] [Related]
19. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
[TBL] [Abstract][Full Text] [Related]
20. A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis.
Communal L; Roy N; Cahuzac M; Rahimi K; Köbel M; Provencher DM; Mes-Masson AM
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
